comparative effectiveness

Research in Review

Recurrence Score Assay Helping to Guide Breast Cancer Decision Making

10/26/2016

JCP Editors

Use of the 21-gene recurrence score (RS) assay is helping clinicians and patients decide which treatments are best for them, according to a large-scale survey of more than 3000 women treated for breast...

Use of...

10/26/2016

Journal of Clinical Pathways

Research in Review

Surgery Plus Chemoradiotherapy Better for Patients With Rectal Cancer

10/25/2016

JCP Editors

Patients with stage II or stage III rectal cancer may have better outcomes when treated with surgery and chemoradiotherapy than those who receive chemoradiotherapy alone, according to an article published in JAMA...

...

10/25/2016

Journal of Clinical Pathways

Research in Review

Androgen Therapy May Improve Survival in Elderly Patients With Leukemia

10/24/2016

JCP Editors

Maintenance therapy with norethandrolone may improve survival in elderly patients with acute myeloid leukemia (AML) without increasing toxicity, according to a study published in the Journal of Clinical Oncology....

...

10/24/2016

Journal of Clinical Pathways

Research in Review

N-Acetyle Cysteine Improves Immunotherapy for Melanoma

10/18/2016

JCP Editors

Culturing T cells in N-acetyle cysteine (NAC) before they are infused as immunotherapy may improve effectiveness and outcomes in patients with melanoma, according to findings reported in Cancer Research....

...

10/18/2016

Journal of Clinical Pathways

Research in Review

Testosterone-Lowering Therapy for Prostate Cancer May Increase Dementia Risk

10/17/2016

JCP Editors

Using testosterone-lowering drugs to treat prostate cancer may make men twice as likely to develop dementia within five years as patients whose testosterone levels were not tampered with, according to a retrospective...

Using...

10/17/2016

Journal of Clinical Pathways

Research in Review

Adjuvant Radiation Therapy Effective in Some Patients With Prostate Cancer

10/16/2016

JCP Editors

Adjuvant radiation therapy may be more effective at treating prostate cancer than no treatment or salvage radiation therapy, according to a recent study published in BJU International. Studies have demonstrated...

...

10/16/2016

Journal of Clinical Pathways

Research in Review

Nivolumab Superior to Standard Therapy for Recurrent Head and Neck Cancer

10/14/2016

JCP Editors

Patients with recurrent or metastatic squamous-cell carcinoma of the head and neck may benefit more from treatment with nivolumab than standard, single agent therapy, according to results from a trial published in...

...

10/14/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz: Week of October 9-15

10/13/2016

JCP Editors

Which of the following drugs added to adjuvant endocrine therapy helped to reduce the risk for contralateral breast cancer in women with invasive breast...

Which...

10/13/2016

Journal of Clinical Pathways

Pharma Insights

Formulary Exclusion Lists Create Challenges for Pharma and Payers Alike

10/12/2016

Andrew Cournoyer, RPh, MBA

Larry Blandford, PharmD—Column Editor

The use of formulary exclusion lists is expanding—and such lists are beginning to shape the market by further limiting available drugs for narrow therapeutic areas while reducing redundancy of options in broader...

The...

10/12/2016

Journal of Clinical Pathways

Research in Review

Mixed Consensus on Cardiovascular Screening Guidelines

10/12/2016

JCP Editors

Primary care physicians play an important role in the prevention of cardiovascular disease (CVD) but still find implementation of prevention strategies challenging, which may be limiting their usage. A review of...

...

10/12/2016

Journal of Clinical Pathways